Indeed, treatment with HMG-CoA reductase inhibitors, which prevent the progression of atherosclerosis, significantly reduced leukocyte counts without affecting basophil counts in patients with coronary artery disease[47]. Here, HMGCR is linked to coronary artery disorder.